US › Healthcare

Align Technology Inc (ALGN)

US · Healthcare · Medical Instruments & Supplies

$173.27+0.22%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$1.06B
Revenue YoY
+4.3%
Net profit
$108.3M
Profit YoY
-13.1%
EPS
$1.83
EPS estimate
$2.08
Net margin
10.3%

EPS came in at 1.83 against a street estimate of 2.08 — a miss of 12.0%.

Key statistics

Market cap
$12.38B
P/E
30.0
Forward P/E
15.0
P/B
2.86
Book value
$59.20
EPS (TTM)
$5.77
52-week high
$200.44
52-week low
$122.00
50-day MA
$173.75
200-day MA
$166.71
Beta
1.65

Analyst view

Analysts rate Align Technology Inc a buy (11 buy, 6 hold, 1 sell out of 18) with an average price target of $210.29.

Shareholding

Insiders
6.82%
Institutions
100.70%

Largest institutional holders

FundStake
Vanguard Group Inc11.42%
Vanguard Capital Management, LLC6.13%
BlackRock Inc5.99%
Capital World Investors5.69%
Capital Research & Mgmt Co - Division 35.32%
Vanguard Portfolio Management, LLC4.40%
FMR Inc3.77%
State Street Corp3.51%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Align Technology Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.